SlideShare a Scribd company logo
1 of 8
Chapter 8 Mini-Case
Megan Voss – Nicki Kollar
Professor Musa Pinar
Marketing Management 304-C
Reading Rainbow...

Creating an application is an example of
modifying a product in order to stay relevant
and not enter the decline stage.

Target market is almost exclusively new-to-
the-brand consumers
Orphan Drugs...

Kynamro helps users with rare cholesterol
diseases, liver diseases, or hepatitis. Patients
cannot survive if these diseases are not treated.

Mynazome primarily affects infants. Pompe
disease can cause death by damaging the heart
and respiratory systems.

Gattex helps treat Short Bowel Syndrome –
when a patient has part of the bowel missing
or removed in surgery.
Orphan Drugs...

If you were an insurance provider, would you
want to caover someone who you know and
has an orphan (rare) disease?
Orphan Drugs...

As a patient, what would you do if, to survive,
you needed a $235,000 drug that you could
not pay for? Raise the funds yourself? Not buy
the medication? Allow the government and
private health plans to foot the bill?
Orphan Drugs...

If you were a pharmaceutical company, would
you take on the risk of manufacturing orphan
drugs? How much would you charge? Would
you feel as though there were ethical problems
in producing these drugs?
Orphan Drugs...

As someone without a rare disease, how do
you feel about your government paying
hundreds of thousands of dollars for thirty
million other Americans' drugs?
Kei Cars...

Kei cars are very small.

They originated in Japan.

American car companies – facing new
regulations – have to consider manufacturing
smaller cars like the kei cars.

Larger SUVs and trucks, by 2025, will reach
their maturity then decline stage if car
companies cannot meet regulations in the
current, larger cars.

More Related Content

Viewers also liked

Calendario escolar-2015-2016 v preliminar
Calendario escolar-2015-2016 v preliminarCalendario escolar-2015-2016 v preliminar
Calendario escolar-2015-2016 v preliminarJack Confra
 
European librarians theatre - Online information : Libraries Go Digital
European librarians theatre - Online information : Libraries Go DigitalEuropean librarians theatre - Online information : Libraries Go Digital
European librarians theatre - Online information : Libraries Go DigitalJulien Houssiere
 
Презентация проекта унф рарус дорхан
Презентация проекта унф рарус дорханПрезентация проекта унф рарус дорхан
Презентация проекта унф рарус дорханАлексей Коломиец
 
Tech Systems - Testing Processes - Beta Testing of Online Exam System - Sanjo...
Tech Systems - Testing Processes - Beta Testing of Online Exam System - Sanjo...Tech Systems - Testing Processes - Beta Testing of Online Exam System - Sanjo...
Tech Systems - Testing Processes - Beta Testing of Online Exam System - Sanjo...Sanjoy Sanyal
 
Automation Skills Gap Fix
Automation Skills Gap FixAutomation Skills Gap Fix
Automation Skills Gap Fixjason_cov
 
Dse4510 dse4520-operator-manual
Dse4510 dse4520-operator-manualDse4510 dse4520-operator-manual
Dse4510 dse4520-operator-manualdeivid_rms
 
iWiW Sandbox vs. Facebook Developers
iWiW Sandbox vs. Facebook DevelopersiWiW Sandbox vs. Facebook Developers
iWiW Sandbox vs. Facebook DevelopersAndrás Király
 
холбоост хичээлийн төлөвлөгөө 2013 2014
холбоост хичээлийн төлөвлөгөө 2013 2014холбоост хичээлийн төлөвлөгөө 2013 2014
холбоост хичээлийн төлөвлөгөө 2013 2014Usukhuu Galaa
 
Aparato circulatorio 4º primaria
Aparato circulatorio 4º primariaAparato circulatorio 4º primaria
Aparato circulatorio 4º primariacurroka
 

Viewers also liked (13)

hicheel2
hicheel2hicheel2
hicheel2
 
Calendario escolar-2015-2016 v preliminar
Calendario escolar-2015-2016 v preliminarCalendario escolar-2015-2016 v preliminar
Calendario escolar-2015-2016 v preliminar
 
European librarians theatre - Online information : Libraries Go Digital
European librarians theatre - Online information : Libraries Go DigitalEuropean librarians theatre - Online information : Libraries Go Digital
European librarians theatre - Online information : Libraries Go Digital
 
Презентация проекта унф рарус дорхан
Презентация проекта унф рарус дорханПрезентация проекта унф рарус дорхан
Презентация проекта унф рарус дорхан
 
Tech Systems - Testing Processes - Beta Testing of Online Exam System - Sanjo...
Tech Systems - Testing Processes - Beta Testing of Online Exam System - Sanjo...Tech Systems - Testing Processes - Beta Testing of Online Exam System - Sanjo...
Tech Systems - Testing Processes - Beta Testing of Online Exam System - Sanjo...
 
Automation Skills Gap Fix
Automation Skills Gap FixAutomation Skills Gap Fix
Automation Skills Gap Fix
 
Dse4510 dse4520-operator-manual
Dse4510 dse4520-operator-manualDse4510 dse4520-operator-manual
Dse4510 dse4520-operator-manual
 
Scm mini project 1
Scm mini project 1Scm mini project 1
Scm mini project 1
 
Input
InputInput
Input
 
iWiW Sandbox vs. Facebook Developers
iWiW Sandbox vs. Facebook DevelopersiWiW Sandbox vs. Facebook Developers
iWiW Sandbox vs. Facebook Developers
 
холбоост хичээлийн төлөвлөгөө 2013 2014
холбоост хичээлийн төлөвлөгөө 2013 2014холбоост хичээлийн төлөвлөгөө 2013 2014
холбоост хичээлийн төлөвлөгөө 2013 2014
 
Aparato circulatorio 4º primaria
Aparato circulatorio 4º primariaAparato circulatorio 4º primaria
Aparato circulatorio 4º primaria
 
GOOGLE MAPS
GOOGLE MAPSGOOGLE MAPS
GOOGLE MAPS
 

Similar to Ch 8 Minicase

Ideal Business Mindset Inc Business Presentation
Ideal Business Mindset Inc Business PresentationIdeal Business Mindset Inc Business Presentation
Ideal Business Mindset Inc Business PresentationFelix Albutra
 
Ethical Implications of Orphan Drug Research Incentives
Ethical Implications of Orphan Drug Research IncentivesEthical Implications of Orphan Drug Research Incentives
Ethical Implications of Orphan Drug Research IncentivesKuldeep Badoniya
 
Is pharma sick of its reputation?
Is pharma sick of its reputation? Is pharma sick of its reputation?
Is pharma sick of its reputation? Pascal Brabant
 
Academic Scientist: Big Pharma is not Interested by your Discovery?
Academic Scientist: Big Pharma is not Interested by your Discovery?Academic Scientist: Big Pharma is not Interested by your Discovery?
Academic Scientist: Big Pharma is not Interested by your Discovery?Ari Massoudi
 
Teresa alves - selling sickness 2010
Teresa alves -  selling sickness 2010Teresa alves -  selling sickness 2010
Teresa alves - selling sickness 2010Gezonde scepsis
 
Coo 10 step marketing plan
Coo 10 step marketing planCoo 10 step marketing plan
Coo 10 step marketing planJoseph Coo
 
Michel Dutree - Selling Sickness 2010
Michel Dutree - Selling Sickness 2010Michel Dutree - Selling Sickness 2010
Michel Dutree - Selling Sickness 2010Gezonde scepsis
 
LET'S MOVE ON TOWARDS WELLNESS starting August 29, 2015 general
LET'S MOVE ON TOWARDS WELLNESS starting August 29, 2015   generalLET'S MOVE ON TOWARDS WELLNESS starting August 29, 2015   general
LET'S MOVE ON TOWARDS WELLNESS starting August 29, 2015 generalArnulfo Laniba
 
Alzeimers 131120140157-phpapp02
Alzeimers 131120140157-phpapp02Alzeimers 131120140157-phpapp02
Alzeimers 131120140157-phpapp02Muvva Pradeep
 
Thalidomide tragedy and History of Medicine
Thalidomide tragedy and History of MedicineThalidomide tragedy and History of Medicine
Thalidomide tragedy and History of MedicineClinosolIndia
 
Orphan Medicinal Product Designation in the EU - By Compliance Global Inc.
Orphan Medicinal Product Designation in the EU  - By Compliance Global Inc.Orphan Medicinal Product Designation in the EU  - By Compliance Global Inc.
Orphan Medicinal Product Designation in the EU - By Compliance Global Inc.Compliance Global Inc
 
Mind Your Step : identifying risk with unlicensed medicines
Mind Your Step : identifying risk with unlicensed medicinesMind Your Step : identifying risk with unlicensed medicines
Mind Your Step : identifying risk with unlicensed medicinesSimon Letellier
 
NEW POWER POINT PRESENTATION ON ORPHAN DISEASES AND DRUGS
NEW POWER POINT PRESENTATION ON ORPHAN DISEASES AND DRUGSNEW POWER POINT PRESENTATION ON ORPHAN DISEASES AND DRUGS
NEW POWER POINT PRESENTATION ON ORPHAN DISEASES AND DRUGSManukonda sravani Reddy
 

Similar to Ch 8 Minicase (15)

Ideal Business Mindset Inc Business Presentation
Ideal Business Mindset Inc Business PresentationIdeal Business Mindset Inc Business Presentation
Ideal Business Mindset Inc Business Presentation
 
Ethical Implications of Orphan Drug Research Incentives
Ethical Implications of Orphan Drug Research IncentivesEthical Implications of Orphan Drug Research Incentives
Ethical Implications of Orphan Drug Research Incentives
 
Is pharma sick of its reputation?
Is pharma sick of its reputation? Is pharma sick of its reputation?
Is pharma sick of its reputation?
 
Academic Scientist: Big Pharma is not Interested by your Discovery?
Academic Scientist: Big Pharma is not Interested by your Discovery?Academic Scientist: Big Pharma is not Interested by your Discovery?
Academic Scientist: Big Pharma is not Interested by your Discovery?
 
Teresa alves - selling sickness 2010
Teresa alves -  selling sickness 2010Teresa alves -  selling sickness 2010
Teresa alves - selling sickness 2010
 
Coo 10 step marketing plan
Coo 10 step marketing planCoo 10 step marketing plan
Coo 10 step marketing plan
 
Michel Dutree - Selling Sickness 2010
Michel Dutree - Selling Sickness 2010Michel Dutree - Selling Sickness 2010
Michel Dutree - Selling Sickness 2010
 
LET'S MOVE ON TOWARDS WELLNESS starting August 29, 2015 general
LET'S MOVE ON TOWARDS WELLNESS starting August 29, 2015   generalLET'S MOVE ON TOWARDS WELLNESS starting August 29, 2015   general
LET'S MOVE ON TOWARDS WELLNESS starting August 29, 2015 general
 
Alzeimers 131120140157-phpapp02
Alzeimers 131120140157-phpapp02Alzeimers 131120140157-phpapp02
Alzeimers 131120140157-phpapp02
 
Thalidomide tragedy and History of Medicine
Thalidomide tragedy and History of MedicineThalidomide tragedy and History of Medicine
Thalidomide tragedy and History of Medicine
 
Orphan Medicinal Product Designation in the EU - By Compliance Global Inc.
Orphan Medicinal Product Designation in the EU  - By Compliance Global Inc.Orphan Medicinal Product Designation in the EU  - By Compliance Global Inc.
Orphan Medicinal Product Designation in the EU - By Compliance Global Inc.
 
Alzeimer’s
Alzeimer’sAlzeimer’s
Alzeimer’s
 
Mind Your Step : identifying risk with unlicensed medicines
Mind Your Step : identifying risk with unlicensed medicinesMind Your Step : identifying risk with unlicensed medicines
Mind Your Step : identifying risk with unlicensed medicines
 
10stepmarketingplan
10stepmarketingplan10stepmarketingplan
10stepmarketingplan
 
NEW POWER POINT PRESENTATION ON ORPHAN DISEASES AND DRUGS
NEW POWER POINT PRESENTATION ON ORPHAN DISEASES AND DRUGSNEW POWER POINT PRESENTATION ON ORPHAN DISEASES AND DRUGS
NEW POWER POINT PRESENTATION ON ORPHAN DISEASES AND DRUGS
 

Ch 8 Minicase

  • 1. Chapter 8 Mini-Case Megan Voss – Nicki Kollar Professor Musa Pinar Marketing Management 304-C
  • 2. Reading Rainbow...  Creating an application is an example of modifying a product in order to stay relevant and not enter the decline stage.  Target market is almost exclusively new-to- the-brand consumers
  • 3. Orphan Drugs...  Kynamro helps users with rare cholesterol diseases, liver diseases, or hepatitis. Patients cannot survive if these diseases are not treated.  Mynazome primarily affects infants. Pompe disease can cause death by damaging the heart and respiratory systems.  Gattex helps treat Short Bowel Syndrome – when a patient has part of the bowel missing or removed in surgery.
  • 4. Orphan Drugs...  If you were an insurance provider, would you want to caover someone who you know and has an orphan (rare) disease?
  • 5. Orphan Drugs...  As a patient, what would you do if, to survive, you needed a $235,000 drug that you could not pay for? Raise the funds yourself? Not buy the medication? Allow the government and private health plans to foot the bill?
  • 6. Orphan Drugs...  If you were a pharmaceutical company, would you take on the risk of manufacturing orphan drugs? How much would you charge? Would you feel as though there were ethical problems in producing these drugs?
  • 7. Orphan Drugs...  As someone without a rare disease, how do you feel about your government paying hundreds of thousands of dollars for thirty million other Americans' drugs?
  • 8. Kei Cars...  Kei cars are very small.  They originated in Japan.  American car companies – facing new regulations – have to consider manufacturing smaller cars like the kei cars.  Larger SUVs and trucks, by 2025, will reach their maturity then decline stage if car companies cannot meet regulations in the current, larger cars.